Closing the gap between alcoholism research and practice: the case for pharmacotherapy.
Meza
E
E
Department of Psychiatry, University of Connecticut School of Medicine, Farmington 06030, USA.
Kranzler
H R
HR
D000437:Alcoholism / Q000188:drug therapy* / Q000628:therapy; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D004221:Disulfiram / Q000627:therapeutic use; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011613:Psychotherapy; D012106:Research; D018490:Serotonin Agents / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D009292:Narcotic Antagonists; D018490:Serotonin Agents; D009271:Naltrexone; D004221:Disulfiram